Publication | Closed Access

A Phase 1 Study to Evaluate the Effect of Crushing, Cutting Into Half, or Grinding of Glecaprevir/Pibrentasvir Tablets on Exposures in Healthy Subjects

Pharmaceutical ScienceHealthy SubjectsPharmacological StudyExcipientsGlecaprevir/pibrentasvir TabletsBioanalysisPharmacologyToxicologyPharmacotherapyMedicinePhase 1Pharmacokinetics